DEMIRE's Asset Sales Are on Schedule — What Each Sale Fetches Is the Whole Test for the Equity

DEMIRE, a German owner of commercial real estate, announced in early September that it sold the Roomers hotel in central Frankfurt to a French fund, IROKO, at the property's last appraised value.sold the Roomers hotel in central Frankfurt to a French fund For a normal company, that sentence would be routine. For DEMIRE, the price tag is the whole story. This is a company that is deliberately shrinking itself to pay down debt, and its shares — worth only about €40 million — trade on nothing except whether each sale confirms the value its balance sheet claims.

The reason starts with what DEMIRE is not growing toward. Its portfolio of 42 properties, roughly 512,000 square meters of offices, retail and hotels in mid-sized German cities and suburbs, carries a stated market value of about €0.9 billion.portfolio of 42 properties, roughly 512,000 square meters But the disposals are the point: the company has been selling assets for years to reduce leverage, focusing its shrinking footprint on the properties that throw off the most funds from operations (FFO). This year's program includes the Frankfurt hotel, an office building in Kempten sold in July at close to its valuation, and a Chemnitz office due to transfer in the fourth quarter at book value — roughly €44 million combined.roughly €44 million combined Sales in Flensburg and part of Bonn added €17.5 million earlier in the year.generated €17.5 million

The money has a specific destination: refinancing a corporate bond. DEMIRE's capital structure centers on €253.7 million of bonds, now paying a 5% coupon and due at the end of 2027.aggregate outstanding principal amount of the extended bond is EUR 253,710,000 That bond is the reason for the whole exercise. It was renegotiated in November 2024 only after the company hit distress — roughly €195 million of Old bonds were bought back and cancelled, funded in part by a shareholder loan of about €93 million.approximately EUR 195.4 million in bonds were repurchased and cancelled Ratings agencies have flagged the refinancing as the key risk: Scope put the company at B-/Positive in December 2024Scope assigns first-time issuer rating of B-/Positive to DEMIRE, and Fitch assigned a CCC+ issuer rating with a B on the bond in mid-2025.issuer rating of 'CCC+'

Here is the gate for the equity. Net debt stands at about €331 million, and net loan-to-value is 42.4%.Net financial debt was EUR 330.8 million That leverage looks manageable by itself — the danger is what the assets earn. FFO I, the closest thing to operating cash flow, came in at just €2 million in the first half of 2026, with full-year guidance of €0.5 to €2.5 million.FFO I: amounted to EUR 2.0 million At DEMIRE's stated 4.74% average cost of debt,average nominal cost of debt fell slightly to 4.74% €331 million of net borrowings costs roughly €16 million a year in interest. The operations do not cover the debt bill; the company is being kept solvent by asset sales and shareholder support, not by its own earnings.

That is what makes the sale price the decisive evidence. The equity is a residual claim — whatever is left after the bond and the shrinkage. The market already prices most of the stated asset value as unrecoverable: a roughly €40 million market capitalizationmarket cap or net worth of EUR 39.04 million sits against a €0.9 billion portfolio, an implied gap of several hundred million euros even before minority interests are deducted. Every disposal that clears at book value confirms the floor is real, because no impairment is being taken and the value on the balance sheet is actually being realized in cash. Roomers matched its last valuation; Kempten came close; Chemnitz transfers at book. Those prints are the provable-value test happening in public.

The headline is that the sales are on schedule. The question an investor should ask is not whether DEMIRE sells, but what each sale fetches. If the disposals keep clearing at book, the bond gets paid down and refinanced against a smaller, less leveraged portfolio, and a residual survives for shareholders. If prices slip, the impairment would hit the equity first, before the bond. Watch each transaction's price against book value between now and the 2027 maturity — that single comparison, repeated sale after sale, will determine whether the equity is a small real claim or a smaller write-off. This was never a growth story; it is a resolution story still being written, one property sale at a time.